Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2017 (2017), Article ID 2412486, 7 pages
https://doi.org/10.1155/2017/2412486
Research Article

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson’s Disease

1Research Team in Neurology and Neurogenetics, Medical School and Pharmacy, Mohammed V University, Rabat, Morocco
2Department of Neurology and Neurogenetics, Specialties Hospital, Rabat, Morocco
3Laboratory of Public Health, Medical School and Pharmacy, Mohammed V University, Rabat, Morocco

Correspondence should be addressed to Ahmed Bouhouche; am.ten.s5mu@ehcuohuob.a

Received 9 December 2016; Accepted 23 March 2017; Published 30 March 2017

Academic Editor: Daniel Berwick

Copyright © 2017 Ahmed Bouhouche et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Copped, “Genetics and epigenetics of Parkinson's disease,” The Scientific World Journal, vol. 2012, Article ID 489830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Thomas and M. Flint Beal, “Parkinson's disease,” Human Molecular Genetics, vol. 16, no. 2, pp. R183–R194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Jankovic, “Parkinson's disease: clinical features and diagnosis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 4, pp. 368–376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. J. Dekker, V. Bonifati, and C. M. Van Duijn, “Parkinson's disease: piecing together a genetic jigsaw,” Brain, vol. 126, no. 8, pp. 1722–1733, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Moore, A. B. West, V. L. Dawson, and T. M. Dawson, “Molecular pathophysiology of Parkinson's disease,” Annual Review of Neuroscience, vol. 28, pp. 57–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Bonifati, “Genetics of Parkinson's disease—state of the art, 2013,” Parkinsonism and Related Disorders, vol. 20, no. 1, pp. S23–S28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. K. Lin and M. J. Farrer, “Genetics and genomics of Parkinson's disease,” Genome Medicine, vol. 6, no. 6, article 48, 2014. View at Google Scholar
  8. P. Gómez-Garre, F. Carrillo, and P. Mir, “Prevalence and clinical features of LRRK2 mutations in patients with Parkinson disease,” European Neurology Journal, vol. 2, pp. 1–7, 2010. View at Google Scholar
  9. D. G. Healy, M. Falchi, S. S. O'Sullivan et al., “Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study,” The Lancet Neurology, vol. 7, no. 7, pp. 583–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. T. S. Benamer and R. De Silva, “LRRK2 G2019S in the North African population: a review,” European Neurology, vol. 63, no. 6, pp. 321–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Lesage, E. Patin, C. Condroyer et al., “Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans,” Human Molecular Genetics, vol. 19, no. 10, Article ID ddq081, pp. 1998–2004, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Kachergus, I. F. Mata, M. Hulihan et al., “Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations,” American Journal of Human Genetics, vol. 76, no. 4, pp. 672–680, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Sierra, I. González-Aramburu, P. Sánchez-Juan et al., “High frequency and reduced penetrance of lRRK2 g2019S mutation among Parkinson's disease patients in Cantabria (Spain),” Movement Disorders, vol. 26, no. 13, pp. 2343–2346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. H. F. Chien, T. R. Figueiredo, M. A. Hollaender et al., “Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson's disease,” Arquivos de Neuro-Psiquiatria, vol. 72, no. 5, pp. 356–359, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Okubadejo, A. Britton, C. Crews et al., “Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3,” PLoS ONE, vol. 3, no. 10, Article ID e3421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Bardien, A. Marsberg, R. Keyser et al., “LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients,” Journal of Neural Transmission, vol. 117, no. 7, pp. 847–853, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Change, G. Mercier, and G. Lucotte, “Genetic screening of the G2019S mutation of the LRRK2 gene in southwest European, North African, and sephardic Jewish subjects,” Genetic Testing, vol. 12, no. 3, pp. 333–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Orr-Urtreger, C. Shifrin, U. Rozovski et al., “The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?” Neurology, vol. 69, no. 16, pp. 1595–1602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. N. Clark, Y. Wang, E. Karlins et al., “Frequency of LRRK2 mutations in early- and late-onset Parkinson disease,” Neurology, vol. 67, no. 10, pp. 1786–1791, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Punia, M. Behari, S. T. Govindappa et al., “Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients,” Neuroscience Letters, vol. 409, no. 2, pp. 83–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. J. Ferreira, L. C. Guedes, M. M. Rosa et al., “High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal,” Movement Disorders, vol. 22, no. 8, pp. 1194–1201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Goldwurm, M. Zini, A. Di Fonzo et al., “LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample,” Parkinsonism and Related Disorders, vol. 12, no. 7, pp. 410–419, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Belarbi, N. Hecham, S. Lesage et al., “LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort,” Parkinsonism and Related Disorders, vol. 16, no. 10, pp. 676–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Schulte and T. Gasser, “Genetic basis of Parkinson's disease: inheritance, penetrance, and expression,” Application of Clinical Genetics, vol. 4, pp. 67–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. W. C. Nichols, N. Pankratz, D. Hernandez et al., “Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease,” Lancet, vol. 365, no. 9457, pp. 410–412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Lesage, P. Ibanez, E. Lohmann et al., “G2019S LRRK2 mutation in French and North African families with Parkinson's disease,” Annals of Neurology, vol. 58, no. 5, pp. 784–787, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Ishihara, R. A. Gibson, L. Warren et al., “Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families,” Movement Disorders, vol. 22, no. 1, pp. 55–61, 2007. View at Publisher · View at Google Scholar
  28. L. Warren, R. Gibson, L. Ishihara et al., “A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease,” Parkinsonism and Related Disorders, vol. 14, no. 1, pp. 77–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Lesage, S. Belarbi, A. Troiano et al., “Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?” Neurology, vol. 71, no. 19, pp. 1550–1552, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. M. Hulihan, L. Ishihara-Paul, J. Kachergus et al., “LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study,” The Lancet Neurology, vol. 7, no. 7, pp. 591–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181–184, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson's disease,” Movement Disorders, vol. 25, no. 15, pp. 2649–2653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-W. Cho, S.-Y. Kim, S.-S. Park, and B. S. Jeon, “The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease and multiple system atrophy,” Journal of Clinical Neurology (Korea), vol. 5, no. 1, pp. 29–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. N. Alcalay, A. Mirelman, R. Saunders-Pullman et al., “Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations,” Movement Disorders, vol. 28, no. 14, pp. 1966–1971, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Puschmann, “Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations,” Parkinsonism and Related Disorders, vol. 19, no. 4, pp. 407–415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. N. L. Khan, S. Jain, J. M. Lynch et al., “Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data,” Brain, vol. 128, no. 12, pp. 2786–2796, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. E. M. Gatto, V. Parisi, D. P. Converso et al., “The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics,” Neuroscience Letters, vol. 537, pp. 1–5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Marras, B. Schuele, R. P. Munhoz et al., “Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers,” Neurology, vol. 77, no. 4, pp. 325–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. L. L. Kilarski, J. P. Pearson, V. Newsway et al., “Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease,” Movement Disorders, vol. 27, no. 12, pp. 1522–1529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Regragui, L. Lachhab, R. Razine et al., “Profile of idiopathic Parkinson's disease in Moroccan patients,” International Archives of Medicine, vol. 7, no. 1, article 10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Ehrminger, S. Leu-Semenescu, F. Cormier et al., “Sleep aspects on video-polysomnography in LRRK2 mutation carriers,” Movement Disorders, vol. 30, no. 13, pp. 1839–1843, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Pont-Sunyer, A. Iranzo, C. Gaig et al., “Sleep disorders in parkinsonian and nonparkinsonian LRRK2 mutation carriers,” PLoS ONE, vol. 10, no. 7, Article ID e0132368, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. D.-W. Li, Z. Gu, C. Wang et al., “Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants,” Journal of Neural Transmission, vol. 122, no. 5, pp. 661–667, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Goldwurm, M. Zini, L. Mariani et al., “Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease,” Neurology, vol. 68, no. 14, pp. 1141–1143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Gosal, O. A. Ross, J. Wiley et al., “Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PD,” Parkinsonism and Related Disorders, vol. 11, no. 6, pp. 349–352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. L. V. Kalia, A. E. Lang, L.-N. Hazrati et al., “Clinical correlations with lewy body pathology in LRRK2-related Parkinson disease,” JAMA Neurology, vol. 72, no. 1, pp. 100–105, 2015. View at Publisher · View at Google Scholar · View at Scopus